Eli Lilly to Acquire Monsanto’s Posilac Artificial Growth Hormone Unit

15:17 PM | August 25, 2008 | Kate Phillips

Monsanto says it has agreed to sell its Posilac recombinant bovine somatotropin (rBST) brand and related business to Eli Lilly for an upfront payment of $300 million, plus possible contingency...